BioNexus Becomes First Nasdaq-Listed Firm To Adopt Ethereum Treasury

March 6, 2025

Medical technology company BioNexus Gene Lab has become the first NASDAQ-listed firm to adopt Ethereum as a strategy reserve asset. 

Search

RECENT PRESS RELEASES